Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Artifactual Displacement of Ductal Carcinoma In Situ (ADDCIS) (Toothpaste Effect): A Mimicker of Invasive Ductal Carcinoma.

Shabihkhani M, Simpson JF, White MJ, Cimino-Mathews A, Argani P.

Am J Surg Pathol. 2019 Sep 9. doi: 10.1097/PAS.0000000000001370. [Epub ahead of print]

PMID:
31503011
2.

Alzheimer's Disease Genetics and ABCA7 Splicing.

Vasquez JB, Simpson JF, Harpole R, Estus S.

J Alzheimers Dis. 2017;59(2):633-641. doi: 10.3233/JAD-170872.

3.

Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.

Lyle PL, Bridge JA, Simpson JF, Cates JM, Sanders ME.

Histopathology. 2016 Jun;68(7):1040-5. doi: 10.1111/his.12898. Epub 2016 Jan 19.

PMID:
26542423
4.

Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up.

Sanders ME, Schuyler PA, Simpson JF, Page DL, Dupont WD.

Mod Pathol. 2015 May;28(5):662-9. doi: 10.1038/modpathol.2014.141. Epub 2014 Dec 12.

5.

A response to the "call to action" on pathologic reporting of lymph node metastases in differentiated thyroid cancer from the college of american pathologists.

Seethala RR, Baker TP, Simpson JF.

Endocr Pathol. 2014 Dec;25(4):441-2. doi: 10.1007/s12022-014-9324-9. No abstract available.

PMID:
25038726
6.

Intranodal papillary epithelial proliferations: a local process with a spectrum of morphologies and frequent association with papillomas in the breast.

Boulos FI, Granja NM, Simpson JF, O'Malley FP, Saadeldine MM, Page DL, Sanders ME.

Am J Surg Pathol. 2014 Mar;38(3):383-8. doi: 10.1097/PAS.0000000000000115. Erratum in: Am J Surg Pathol. 2014 May;38(5):728. Sanders, Melina E [corrected to Sanders, Melinda E].

PMID:
24525508
7.

CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.

Malik M, Simpson JF, Parikh I, Wilfred BR, Fardo DW, Nelson PT, Estus S.

J Neurosci. 2013 Aug 14;33(33):13320-5. doi: 10.1523/JNEUROSCI.1224-13.2013.

8.

The pathologist as a teacher.

Simpson JF, Washington K.

Am J Clin Pathol. 2012 Sep;138(3):320. doi: 10.1309/AJCPDUMLZI2LT1SB. No abstract available.

PMID:
22912346
9.

Genetics of clusterin isoform expression and Alzheimer's disease risk.

Ling IF, Bhongsatiern J, Simpson JF, Fardo DW, Estus S.

PLoS One. 2012;7(4):e33923. doi: 10.1371/journal.pone.0033923. Epub 2012 Apr 10.

10.

Definitive diagnosis for high-risk breast lesions without open surgical excision: the Intact Percutaneous Excision Trial (IPET).

Whitworth PW, Simpson JF, Poller WR, Schonholz SM, Turner JF, Phillips RF, Johnson JM, McEachin FD.

Ann Surg Oncol. 2011 Oct;18(11):3047-52. doi: 10.1245/s10434-011-1911-0. Epub 2011 Sep 27.

PMID:
21947585
11.

Can we know what to do when DCIS is diagnosed?

Sanders ME, Simpson JF.

Oncology (Williston Park). 2011 Aug;25(9):852-6.

12.

Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role.

Boulos FI, Dupont WD, Schuyler PA, Sanders ME, Page DL, Fedda FA, Simpson JF.

Cancer. 2012 May 1;118(9):2372-7. doi: 10.1002/cncr.26523. Epub 2011 Sep 14.

13.

Expression and regulation of a low-density lipoprotein receptor exon 12 splice variant.

Ling IF, Gopalraj RK, Simpson JF, Estus S.

J Neurochem. 2010 Nov;115(3):614-24. doi: 10.1111/j.1471-4159.2010.06972.x. Epub 2010 Sep 28.

14.

Foamy cell angiosarcoma: a rare and deceptively bland variant of cutaneous angiosarcoma.

Tatsas AD, Keedy VL, Florell SR, Simpson JF, Coffin CM, Kelley MC, Cates JM.

J Cutan Pathol. 2010 Aug;37(8):901-6. doi: 10.1111/j.1600-0560.2010.01512.x. Epub 2010 Feb 8.

PMID:
20175826
15.

Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Grear KE, Ling IF, Simpson JF, Furman JL, Simmons CR, Peterson SL, Schmitt FA, Markesbery WR, Liu Q, Crook JE, Younkin SG, Bu G, Estus S.

Mol Neurodegener. 2009 Nov 4;4:46. doi: 10.1186/1750-1326-4-46.

16.

Differential Diagnosis of Proliferative Breast Lesions.

Simpson JF, Boulos FI.

Surg Pathol Clin. 2009 Jun;2(2):235-46. doi: 10.1016/j.path.2009.02.002. Epub 2009 Jun 2. Review.

PMID:
26838320
17.

Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.

Yentzer BA, Yelverton CB, Simpson GL, Simpson JF, Hwang W, Balkrishnan R, Feldman SR.

Dermatol Online J. 2009 Apr 15;15(4):1.

18.

Update on atypical epithelial hyperplasia and ductal carcinoma in situ.

Simpson JF.

Pathology. 2009 Jan;41(1):36-9. doi: 10.1080/00313020802568097. Review.

PMID:
19089738
19.

Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study.

Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME, Page DL.

Cancer. 2008 Nov 1;113(9):2415-21. doi: 10.1002/cncr.23873.

20.

Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.

Zou F, Gopalraj RK, Lok J, Zhu H, Ling IF, Simpson JF, Tucker HM, Kelly JF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Bennett DA, Crook JE, Younkin SG, Estus S.

Hum Mol Genet. 2008 Apr 1;17(7):929-35. Epub 2007 Dec 8.

21.

A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol.

Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, Cupples LA, Estus S.

Hum Mol Genet. 2007 Jul 15;16(14):1765-72. Epub 2007 May 21.

22.

Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy.

McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL.

Cancer. 2006 Sep 15;107(6):1227-33.

23.

Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.

Simpson JF, Yelverton CB, Balkrishnan R, Fleischer A Jr, Lide W, Feldman SR.

Manag Care Interface. 2006 Jun;19(6):39-43.

PMID:
16892660
24.

Uterine effects of tamoxifen: a prospective study.

McGonigle KF, Smith DD, Marx HF, Morgan RJ, Vasilev SA, Roy S, Wong PT, Simpson JF, Wilczynski SP.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):814-20.

PMID:
16681767
25.

Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer.

Chakravarthy AB, Kelley MC, McLaren B, Truica CI, Billheimer D, Mayer IA, Grau AM, Johnson DH, Simpson JF, Beauchamp RD, Jones C, Pietenpol JA.

Clin Cancer Res. 2006 Mar 1;12(5):1570-6.

26.

Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies.

Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD.

Cancer. 2006 Apr 1;106(7):1453-61.

27.

Selective use of intraoperative touch prep analysis of sentinel nodes in breast cancer.

Forbes RC, Pitchford C, Simpson JF, Balch GC, Kelley MC.

Am Surg. 2005 Nov;71(11):955-60; discussion 961-2.

PMID:
16372615
28.

Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection.

Muldrew KL, Simpson JF, Stratton CW, Tang YW.

J Mol Diagn. 2005 Nov;7(5):641-5.

29.

What is atypical lobular hyperplasia and what does it mean for the patient?

Page DL, Simpson JF.

J Clin Oncol. 2005 Aug 20;23(24):5432-3. No abstract available.

PMID:
16110003
30.

Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy.

Balch GC, Mithani SK, Simpson JF, Kelley MC.

Am Surg. 2005 Jan;71(1):22-7; discussion 27-8.

PMID:
15757052
31.

Lobulocentricity of breast hypersecretory hyperplasia with cytologic atypia: infrequent association with carcinoma in situ.

Kasami M, Jensen RA, Simpson JF, Page DL.

Am J Clin Pathol. 2004 Nov;122(5):714-20.

PMID:
15491967
32.

Historical and epidemiologic background of human premalignant breast disease.

Page DL, Jensen RA, Simpson JF, Dupont WD.

J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):341-9. Review.

PMID:
14973380
33.

Inflammatory myofibroblastic tumour of the breast: report of a case with giant vacuolated cells.

Gobbi H, Atkinson JB, Kardos TF, Simpson JF, Page DL.

Breast. 1999 Jun;8(3):135-8.

PMID:
14965731
34.

Androgen receptor CAG repeat lengths in ductal carcinoma in situ of breast, longest in apocrine variety.

Kasami M, Gobbi H, Dupont WD, Simpson JF, Page DL, Vnencak-Jones CL.

Breast. 2000 Feb;9(1):23-7.

PMID:
14731580
35.

Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas.

Gobbi H, Simpson JF, Jensen RA, Olson SJ, Page DL.

Mod Pathol. 2003 Sep;16(9):893-901.

36.

Microglandular adenosis with transition into adenoid cystic carcinoma of the breast.

Acs G, Simpson JF, Bleiweiss IJ, Hugh J, Reynolds C, Olson S, Page DL.

Am J Surg Pathol. 2003 Aug;27(8):1052-60.

PMID:
12883237
37.

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.

Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF.

Lancet. 2003 Jan 11;361(9352):125-9. Erratum in: Lancet. 2003 Jun 7;361(9373):1994.

PMID:
12531579
38.

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.

Somlo G, Simpson JF, Frankel P, Chow W, Leong L, Margolin K, Morgan R Jr, Raschko J, Shibata S, Forman S, Kogut N, McNamara M, Molina A, Somlo E, Doroshow JH.

Br J Cancer. 2002 Jul 29;87(3):281-8.

39.

Glial cell line-derived neurotrophic factor is a survival factor for isolectin B4-positive, but not vanilloid receptor 1-positive, neurons in the mouse.

Zwick M, Davis BM, Woodbury CJ, Burkett JN, Koerber HR, Simpson JF, Albers KM.

J Neurosci. 2002 May 15;22(10):4057-65.

40.
41.

What is apocrine adenosis, anyway?

Page DL, Simpson JF.

Histopathology. 2001 Oct;39(4):433-4. No abstract available.

PMID:
11683946
42.

Pathology of preinvasive and excellent prognosis breast cancer.

Simpson JF, Page DL.

Curr Opin Oncol. 2001 Nov;13(6):426-30. Review.

PMID:
11673681
43.

Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.

Gobbi H, Jensen RA, Simpson JF, Olson SJ, Page DL.

Hum Pathol. 2001 Aug;32(8):785-90.

PMID:
11521220
44.

Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting.

Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL.

Am J Surg Pathol. 2001 Aug;25(8):1017-21.

PMID:
11474285
45.

No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia.

Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, Dupont WD.

Cancer. 2001 Jul 1;92(1):30-6.

PMID:
11443606
46.

p53 in Mammary ductal carcinoma in situ, mutations in high-grade lesions only?

Simpson JF, Page DL, Edgerton ME.

J Natl Cancer Inst. 2001 May 2;93(9):666-7. No abstract available.

PMID:
11333279
47.

Pathology of preinvasive and excellent-prognosis breast cancer.

Page DL, Simpson JF.

Curr Opin Oncol. 2000 Nov;12(6):526-31. Review.

PMID:
11085451
48.

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, Arteaga CL.

Cancer Res. 2000 Oct 15;60(20):5887-94.

49.

Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen.

Mizobata S, Tompkins K, Simpson JF, Shyr Y, Primus FJ.

Cancer Immunol Immunother. 2000 Aug;49(6):285-95.

PMID:
10946810
50.

Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

Lenferink AE, Simpson JF, Shawver LK, Coffey RJ, Forbes JT, Arteaga CL.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9609-14.

Supplemental Content

Loading ...
Support Center